WallStreetZenWallStreetZen

NYSE: BSX
Boston Scientific Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Boston Scientific earnings were $1.8B for the trailing 12 months ending Sep 30, 2024, with 48.8% growth year over year. The latest BSX earnings report on Sep 30, 2024 announced Q3 2024 earnings of $469.0M, up 44.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, BSX reported annual earnings of $1.6B, with 144.5% growth. The next BSX earnings date is Jan 29, 2025.

BSX past earnings growth

How has BSX's earnings growth performed historically?

Company
48.78%
Industry
39.53%
Market
48.2%
BSX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BSX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BSX's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BSX earnings history

Current Revenue
$15.9B
Current Earnings
$1.8B
Current Profit Margin
11.3%
BSX's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BSX Return on Equity

Current Company
8.9%
Current Industry
11.4%
Current Market
35%
BSX's Return on Equity (8.9%)... subscribe to Premium to read more.
High Return on Equity Performance

BSX Return on Assets

Current Company
4.9%
Current Industry
6.6%
BSX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BSX announces earnings.

BSX Return on Capital Employed

Current Company
7.76%
Current Industry
8.8%
BSX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BSX vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BSX$3.73B$1.79B+9.08%$1.22
SYK$4.61B$3.59B+0.58%$9.43
MDT$8.53B$4.29B-1.12%$3.29
ABT$10.58B$5.77B+12.15%$3.30
EW$4.53B$4.16B+41.05%$6.94
View Top Medical Device Stocks

BSX earnings dates

Next earnings date
Jan 29, 2025

Boston Scientific Earnings Reports & History FAQ

What were Boston Scientific's earnings last quarter?

On BSX's earnings call on Invalid Date, Boston Scientific (NYSE: BSX) reported Q3 2024 earnings per share (EPS) of $0.32, up 5.88% year over year. Total BSX earnings for the quarter were $469.00 million. In the same quarter last year, Boston Scientific's earnings per share (EPS) was $0.34.

If you're new to stock investing, here's how to buy Boston Scientific stock.

When does Boston Scientific report earnings?

The next BSX earnings call is Invalid Date. Add BSX to your watchlist to be reminded of Boston Scientific's next earnings date.

What was BSX's earnings growth in the past year?

As of Boston Scientific's earnings date in Invalid Date, Boston Scientific's earnings has grown 48.78% year over year. This is 9.25 percentage points higher than the US Medical Devices industry earnings growth rate of 39.53%. BSX earnings in the past year totalled $1.79 billion.

Is Boston Scientific profitable or losing money?

As of the last Boston Scientific earnings report, Boston Scientific is currently profitable. Boston Scientific's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $1.79 billion, a 45.85% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.